NM_021098.3:c.5081T>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_021098.3(CACNA1H):c.5081T>C(p.Met1694Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,608,770 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1694V) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.5081T>C | p.Met1694Thr | missense_variant | Exon 29 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.5096T>C | p.Met1699Thr | missense_variant | Exon 28 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.5099T>C | p.Met1700Thr | missense_variant | Exon 28 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.5063T>C | p.Met1688Thr | missense_variant | Exon 28 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.5096T>C | p.Met1699Thr | missense_variant | Exon 29 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.5081T>C | p.Met1694Thr | missense_variant | Exon 29 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.5042T>C | p.Met1681Thr | missense_variant | Exon 29 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.5063T>C | p.Met1688Thr | missense_variant | Exon 28 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.5024T>C | p.Met1675Thr | missense_variant | Exon 28 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.5081T>C | p.Met1694Thr | missense_variant | Exon 29 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.5063T>C | p.Met1688Thr | missense_variant | Exon 28 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.5081T>C | p.Met1694Thr | missense_variant | Exon 29 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.5081T>C | p.Met1694Thr | missense_variant | Exon 29 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.5081T>C | p.Met1694Thr | missense_variant | Exon 29 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.5081T>C | non_coding_transcript_exon_variant | Exon 29 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*1033T>C | non_coding_transcript_exon_variant | Exon 28 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*162T>C | non_coding_transcript_exon_variant | Exon 29 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2932T>C | non_coding_transcript_exon_variant | Exon 29 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4525T>C | non_coding_transcript_exon_variant | Exon 27 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.5063T>C | non_coding_transcript_exon_variant | Exon 28 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.5063T>C | non_coding_transcript_exon_variant | Exon 28 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*82T>C | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.5081T>C | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.5081T>C | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.5063T>C | non_coding_transcript_exon_variant | Exon 28 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.5081T>C | non_coding_transcript_exon_variant | Exon 29 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.5081T>C | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*82T>C | non_coding_transcript_exon_variant | Exon 28 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*1033T>C | 3_prime_UTR_variant | Exon 28 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*162T>C | 3_prime_UTR_variant | Exon 29 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2932T>C | 3_prime_UTR_variant | Exon 29 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4525T>C | 3_prime_UTR_variant | Exon 27 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*82T>C | 3_prime_UTR_variant | Exon 29 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*82T>C | 3_prime_UTR_variant | Exon 28 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152232Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000417 AC: 10AN: 239896 AF XY: 0.00000767 show subpopulations
GnomAD4 exome AF: 0.000226 AC: 329AN: 1456420Hom.: 0 Cov.: 33 AF XY: 0.000222 AC XY: 161AN XY: 724014 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74500 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.5081T>C (p.M1694T) alteration is located in exon 29 (coding exon 28) of the CACNA1H gene. This alteration results from a T to C substitution at nucleotide position 5081, causing the methionine (M) at amino acid position 1694 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 529593). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. This variant is present in population databases (rs375015931, gnomAD 0.009%). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1694 of the CACNA1H protein (p.Met1694Thr). -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at